1
|
Guglietta F, Behr M, Falcucci G, Sbragaglia M. Loading and relaxation dynamics of a red blood cell. SOFT MATTER 2021; 17:5978-5990. [PMID: 34048527 DOI: 10.1039/d1sm00246e] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
We use mesoscale numerical simulations to investigate the unsteady dynamics of a single red blood cell (RBC) subjected to an external mechanical load. We carry out a detailed comparison between the loading (L) dynamics, following the imposition of the mechanical load on the RBC at rest, and the relaxation (R) dynamics, allowing the RBC to relax to its original shape after the sudden arrest of the mechanical load. Such a comparison is carried out by analyzing the characteristic times of the two corresponding dynamics, i.e., tL and tR. When the intensity of the mechanical load is small enough, the two kinds of dynamics are symmetrical (tL≈tR) and independent of the typology of mechanical load (intrinsic dynamics); otherwise, in marked contrast, an asymmetry is found, wherein the loading dynamics is typically faster than the relaxation one. This asymmetry manifests itself with non-universal characteristics, e.g., dependency on the applied load and/or on the viscoelastic properties of the RBC membrane. To deepen such a non-universal behaviour, we consider the viscosity of the erythrocyte membrane as a variable parameter and focus on three different typologies of mechanical load (mechanical stretching, shear flow, elongational flow): this allows to clarify how non-universality builds up in terms of the deformation and rotational contributions induced by the mechanical load on the membrane. Finally, we also investigate the effect of the elastic shear modulus on the characteristic times tL and tR. Our results provide crucial and quantitative information on the unsteady dynamics of RBC and its membrane response to the imposition/cessation of external mechanical loads.
Collapse
Affiliation(s)
- Fabio Guglietta
- Department of Physics & INFN, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133, Rome, Italy. and Chair for Computational Analysis of Technical Systems (CATS), RWTH Aachen University, 52056 Aachen, Germany and Computation-Based Science and Technology Research Center, The Cyprus Institute, 20 Konstantinou Kavafi Str., 2121 Nicosia, Cyprus
| | - Marek Behr
- Chair for Computational Analysis of Technical Systems (CATS), RWTH Aachen University, 52056 Aachen, Germany
| | - Giacomo Falcucci
- Department of Enterprise Engineering "Mario Lucertini", University of Rome "Tor Vergata", Via del Politecnico 1, 00133 Rome, Italy and Department of Physics, Harvard University, 17 Oxford Street, 02138 Cambridge, Massachusetts, USA
| | - Mauro Sbragaglia
- Department of Physics & INFN, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133, Rome, Italy.
| |
Collapse
|
2
|
Guglietta F, Behr M, Biferale L, Falcucci G, Sbragaglia M. On the effects of membrane viscosity on transient red blood cell dynamics. SOFT MATTER 2020; 16:6191-6205. [PMID: 32567630 DOI: 10.1039/d0sm00587h] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Computational Fluid Dynamics (CFD) is currently used to design and improve the hydraulic properties of biomedical devices, wherein the large scale blood circulation needs to be simulated by accounting for the mechanical response of red blood cells (RBCs) at the mesoscale. In many practical instances, biomedical devices work on time-scales comparable to the intrinsic relaxation time of RBCs: thus, a systematic understanding of the time-dependent response of erythrocyte membranes is crucial for the effective design of such devices. So far, this information has been deduced from experimental data, which do not necessarily adapt to the broad variety of fluid dynamic conditions that can be encountered in practice. This work explores the novel possibility of studying the time-dependent response of an erythrocyte membrane to external mechanical loads via mesoscale numerical simulations, with a primary focus on the detailed characterisation of the RBC relaxation time tc following the arrest of the external mechanical load. The adopted mesoscale model exploits a hybrid Immersed Boundary-Lattice Boltzmann Method (IB-LBM), coupled with the Standard Linear Solid (SLS) model to account for the RBC membrane viscosity. We underscore the key importance of the 2D membrane viscosity μm to correctly reproduce the relaxation time of the RBC membrane. A detailed assessment of the dependencies on the typology and strength of the applied mechanical loads is also provided. Overall, our findings open interesting future perspectives for the study of the non-linear response of RBCs immersed in time-dependent strain fields.
Collapse
Affiliation(s)
- Fabio Guglietta
- Department of Physics & INFN, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133, Rome, Italy. and Chair for Computational Analysis of Technical Systems (CATS), RWTH Aachen University, 52056 Aachen, Germany and Computation-Based Science and Technology Research Center, The Cyprus Institute, 20 Konstantinou Kavafi Str., 2121 Nicosia, Cyprus
| | - Marek Behr
- Chair for Computational Analysis of Technical Systems (CATS), RWTH Aachen University, 52056 Aachen, Germany
| | - Luca Biferale
- Department of Physics & INFN, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133, Rome, Italy.
| | - Giacomo Falcucci
- Department of Enterprise Engineering "Mario Lucertini", University of Rome "Tor Vergata", Via del Politecnico 1, 00133 Rome, Italy and John A. Paulson School of Engineering and Applied Physics, Harvard University, 33 Oxford Street, 02138 Cambridge, Massachusetts, USA
| | - Mauro Sbragaglia
- Department of Physics & INFN, University of Rome "Tor Vergata", Via della Ricerca Scientifica 1, 00133, Rome, Italy.
| |
Collapse
|
3
|
Sensor-Based Physiologic Control Strategy for Biventricular Support with Rotary Blood Pumps. ASAIO J 2017; 64:338-350. [PMID: 28938308 DOI: 10.1097/mat.0000000000000671] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Rotary biventricular assist devices (BiVAD) are becoming a clinically accepted treatment option for end-stage biventricular failure. To improve BiVAD efficacy and safety, we propose a control algorithm to achieve the clinical objectives of maintaining left-right-sided balance, restoring physiologic flows, and preventing ventricular suction. The control algorithm consists of two proportional-integral (PI) controllers for left and right ventricular assist devices (LVAD and RVAD) to maintain differential pump pressure across LVAD (ΔPL) and RVAD (ΔPR) to provide left-right balance and physiologic flow. To prevent ventricular suction, LVAD and RVAD pump speed differentials (ΔRPML, ΔRPMR) were maintained above user-defined thresholds. Efficacy and robustness of the proposed algorithm were tested in silico for axial and centrifugal flow BiVAD using 1) normal and excessive ΔPL and/or ΔPR setpoints, 2) rapid threefold increase in pulmonary vascular or vena caval resistances, 3) transient responses from exercise to rest, and 4) ventricular fibrillation. The study successfully demonstrated that the proposed BiVAD algorithm achieved the clinical objectives but required pressure sensors to continuously measure ΔPL and ΔPR. The proposed control algorithm is device independent, should not require any modifications to the pump or inflow/outflow cannulae/grafts, and may be directly applied to current rotary blood pumps for biventricular support.
Collapse
|
4
|
Moazami N, Hoercher KJ, Fukamachi K, Kobayashi M, Smedira NG, Massiello A, Horvath DJ. Mechanical circulatory support for heart failure: past, present and a look at the future. Expert Rev Med Devices 2013; 10:55-71. [PMID: 23278224 DOI: 10.1586/erd.12.69] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Heart transplantation remains the gold standard for long-term cardiac replacement, but a shortage of donor organs will always limit this option. For both transplant-eligible and noneligible patients, advances in mechanical circulatory support have revolutionized the options for the management of end-stage heart failure, and this technology continues to bring us closer to a true alternative to heart transplantation. This review provides a perspective on the past, present and future of mechanical circulatory support and addresses the changes in technology, patient selection and management strategies needed to have this therapy fully embraced by the heart failure community, and perhaps replace heart transplantation either as the therapy of choice or as a strategy by which to delay transplantation in younger patients.
Collapse
Affiliation(s)
- Nader Moazami
- Department of Thoracic and Cardiovascular Surgery, Miller Family Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
| | | | | | | | | | | | | |
Collapse
|
5
|
Lee Y, Chang JK, Lee SH, Jang JU, Lee KB, Lee HW, Sun K, Kim HM, Kim J, Yoo JY. Development of Magnetically Suspended Vaneless Centrifugal Blood Pump for Cardiopulmonary Bypass. J MECH MED BIOL 2011. [DOI: 10.1142/s0219519403000697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
An ideal blood pump would provide sufficient flow rate against vessel pressure without hemolysis or thrombus formation. In preceding studies, it is known that non-contact operation by magnetic bearing system gives high mechanical reliability, low hemolysis and low thrombus formation. Therefore, in the present study a magnetically suspended vaneless centrifugal blood pump (MSVC-BP) has been developed for the use of cardiopulmonary bypass, in which the magnetic suspension centers the centrifugal rotor avoiding any contact. To predict the flow pattern in the pump head and to calculate shear stress on the rotor, numerical analysis has been performed using the TASCflow®. In vitro tests of hydrodynamic performance of the present pump have been carried out in mock circular system with glycerin solution, attaining a maximum flow rate of 12 L/min at 2200 rpm. In vivo tests of hemodynamic performance of the pump have also led to reasonable results for clinical usage.
Collapse
Affiliation(s)
- Y. Lee
- School of Mechanical and Aerospace Engineering, Seoul National University, San 56-1, Shilim-dong, Kwanak-gu, Seoul, 151-742, Korea
| | - J. K. Chang
- School of Electrical Engineering and Computer Science, Seoul National University, San 56-1, Shilim-dong, Kwanak-gu, Seoul, 151-742, Korea
| | - S. H. Lee
- School of Mechanical and Aerospace Engineering, Seoul National University, San 56-1, Shilim-dong, Kwanak-gu, Seoul, 151-742, Korea
| | - J. U. Jang
- School of Mechanical and Aerospace Engineering, Seoul National University, San 56-1, Shilim-dong, Kwanak-gu, Seoul, 151-742, Korea
| | - K. B. Lee
- Department of Biomedical Engineering, Korea University, 1, 5-ga, Anam-dong, Sungbuk-gu, Seoul, 136-701, Korea
| | - H. W. Lee
- Department of Anesthesiology, Korea University Hospital, 126-1, 5-ga, Anam-dong, Sungbuk-gu, Seoul, 136-705, Korea
| | - K. Sun
- Department of Thoracic and Cardiovascular Surgery, Korea University Hospital, 126-1, 5-ga, Anam-dong, Sungbuk-gu, Seoul, 136-705, Korea
| | - H. M. Kim
- Department of Thoracic and Cardiovascular Surgery, Korea University Hospital, 126-1, 5-ga, Anam-dong, Sungbuk-gu, Seoul, 136-705, Korea
| | - J. Kim
- Biomedlab Co., 4F, Dongsung-building, 1-49, Dongsung-dong, Jongno-gu, Seoul, 110-809, Korea
| | - J. Y. Yoo
- School of Mechanical and Aerospace Engineering, Seoul National University, San 56-1, Shilim-dong, Kwanak-gu, Seoul, 151-742, Korea
| |
Collapse
|
6
|
Biventricular Assist Devices: A Technical Review. Ann Biomed Eng 2011; 39:2313-28. [DOI: 10.1007/s10439-011-0348-8] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2011] [Accepted: 06/28/2011] [Indexed: 01/16/2023]
|
7
|
da Silva I, Horikawa O, Cardoso JR, Camargo FA, Andrade AJP, Bock EGP. Single axis controlled hybrid magnetic bearing for left ventricular assist device: hybrid core and closed magnetic circuit. Artif Organs 2011; 35:448-53. [PMID: 21595710 DOI: 10.1111/j.1525-1594.2011.01265.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
In previous studies, we presented main strategies for suspending the rotor of a mixed-flow type (centrifugal and axial) ventricular assist device (VAD), originally presented by the Institute Dante Pazzanese of Cardiology (IDPC), Brazil. Magnetic suspension is achieved by the use of a magnetic bearing architecture in which the active control is executed in only one degree of freedom, in the axial direction of the rotor. Remaining degrees of freedom, excepting the rotation, are restricted only by the attraction force between pairs of permanent magnets. This study is part of a joint project in development by IDPC and Escola Politecnica of São Paulo University, Brazil. This article shows advances in that project, presenting two promising solutions for magnetic bearings. One solution uses hybrid cores as electromagnetic actuators, that is, cores that combine iron and permanent magnets. The other solution uses actuators, also of hybrid type, but with the magnetic circuit closed by an iron core. After preliminary analysis, a pump prototype has been developed for each solution and has been tested. For each prototype, a brushless DC motor has been developed as the rotor driver. Each solution was evaluated by in vitro experiments and guidelines are extracted for future improvements. Tests have shown good results and demonstrated that one solution is not isolated from the other. One complements the other for the development of a single-axis-controlled, hybrid-type magnetic bearing for a mixed-flow type VAD.
Collapse
Affiliation(s)
- Isaias da Silva
- Department of Exact Sciences and Earth, Federal University of São Paulo, Rua Prof. Artur Riedel 275, Diadema CEP 09972-270, SP, Brazil.
| | | | | | | | | | | |
Collapse
|
8
|
Gaddum NR, Timms DL, Pearcy MJ. Optimizing the Response From a Passively Controlled Biventricular Assist Device. Artif Organs 2010; 34:393-401. [DOI: 10.1111/j.1525-1594.2009.00870.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
Saeed D, Zahr R, Shalli S, Fumoto H, Horai T, Anzai T, Arakawa Y, Dessoffy R, Catanese J, Golding LAR, Fukamachi K. Median sternotomy approach for chronic bovine experiments. ASAIO J 2008; 54:585-8. [PMID: 19033770 PMCID: PMC2782521 DOI: 10.1097/mat.0b013e31818a30d9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Lateral thoracotomy is the traditional surgical approach for preclinical animal testing of various ventricular assist devices. Median sternotomy, however, is regarded from a functional standpoint as the most appropriate approach for cardiac surgical procedures, particularly for device implantation. The purpose of this study was to evaluate the outcomes of performing a median sternotomy in chronic bovine studies. Three chronic studies using the sternotomy approach were performed. Surgical access was compared to the lateral thoracotomy approach used in three other animal experiments. Postoperative speed of recovery, pain management, sternotomy incision, and monitoring line exit site healing and infection were also evaluated. With sternotomy, better surgical access to all cardiac chambers and great vessels and more room for device placement were achieved. The recovery time was similar to that using the lateral thoracotomy approach, with no additional difficulties observed in standing or recumbency and no need for increased pain management. At the time of autopsy, the sternum was well healed without any sign of infection. In conclusion, these studies showed that a median sternotomy can be used successfully for chronic bovine studies. This approach will be used for our future biventricular assist device implantation surgeries.
Collapse
Affiliation(s)
- Diyar Saeed
- Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Abstract
An implantable biventricular assist device offers a considerable opportunity to save the lives of patients with combined irreversible right and left ventricular failure. The purpose of this study was to evaluate the hemodynamic and physiologic performance of the combined implantation of the CorAide left ventricular assist device (LVAD) and the DexAide right ventricular assist device (RVAD). Acute hemodynamic responses were evaluated after simulating seven different physiological conditions in two calves. Evaluation was performed by fixing the speed of one individual pump and increasing the speed of the other. Under all conditions, increased LVAD or RVAD speed resulted in increased pump flow. The predominant pathophysiologic effect of independently varying DexAide and CorAide pump speeds was that the left atrial pressure was very sensitive to increasing RVAD speed above 2,400 rpm, whereas the right atrial pressure demonstrated much less sensitivity to increasing LVAD speed. An increase in aortic pressure and RVAD flow was observed while increasing LVAD speed, especially under low contractility, ventricular fibrillation, high pulmonary artery pressure, and low circulatory blood volume conditions. In conclusion, a proper RVAD-LVAD balance should be maintained by avoiding RVAD overdrive. Additional studies will further investigate the performance of these pumps in chronic animal models.
Collapse
|
11
|
Furukawa K, Motomura T, Nosé Y. Right ventricular failure after left ventricular assist device implantation: the need for an implantable right ventricular assist device. Artif Organs 2006; 29:369-77. [PMID: 15854212 DOI: 10.1111/j.1525-1594.2005.29063.x] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Right ventricular failure after implantation of a left ventricular assist device is an unremitting problem. Consideration of portal circulation is important for reversing liver dysfunction and preventing multiple organ failure after left ventricular assist device implantation. To achieve these objectives, it is imperative to maintain the central venous pressure as low as possible. A more positive application of right ventricular assistance is recommended. Implantable pulsatile left ventricular assist devices cannot be used as a right ventricular assist device because of their structure and device size. To improve future prospects, it is necessary to develop an implantable right ventricular assist device based on a rotary blood pump.
Collapse
Affiliation(s)
- Kojiro Furukawa
- Michael E. DeBakey Department of Surgery, Division of Transplant Surgery and Assist Devices, Center for Artificial Organ Development, Baylor College of Medicine, Houston, TX, USA.
| | | | | |
Collapse
|
12
|
Furukawa K, Motomura T, Hata A, Asai T, Yuri K, Iwahashi H, Tanaka A, Nosi Y. Development of implantable right ventricular assist device. ASAIO J 2005; 50:543-9. [PMID: 15672786 DOI: 10.1097/01.mat.0000145843.25945.34] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Implantable ventricular assist devices (VADs) are indicated for long waiting periods before transplantation and also as a destination therapy. Meanwhile, right ventricular failure (RVF) is one of the four major complications observed in patients after left VAD (LVAD) implantation, with an incidence of approximately 20%. Preoperative prediction of the complication remains difficult, and the mortality is very high. To date, no implantable right VAD (RVAD) is available for the clinical situation. The possibility of realizing an implantable RVAD with Gyro centrifugal pump (PI-710 pump) was investigated. Eleven chronic animal experiments with LVAD and RVAD implantation were performed. Right heart bypass was established between right outflow and pulmonary trunk, and the pump was implanted in the preperitoneal space. The anatomic fit was good. The mean term of the experiments was 59 days, with excellent pump performance. Stable pulmonary hemodynamics and respiratory function were maintained during all of the experimental terms. No specific abnormal histologic findings of the lung were confirmed; however, tunica media hypertrophy was recognized in some cases. The PI-710 pump is feasible as a clinically implantable RVAD, but further study of histologic and pulmonary vascular changes after RVAD implantation is needed.
Collapse
Affiliation(s)
- Kojiro Furukawa
- Michael E. DeBakey Department of Surgery, Division of Transplant Surgery and Assist Devices, Center for Artificial Organ Development, Baylor College of Medicine, Houston, Texas, USA
| | | | | | | | | | | | | | | |
Collapse
|
13
|
Takatani S, Matsuda H, Hanatani A, Nojiri C, Yamazaki K, Motomura T, Ohuchi K, Sakamoto T, Yamane T. Mechanical circulatory support devices (MCSD) in Japan: current status and future directions. J Artif Organs 2005; 8:13-27. [PMID: 15951976 DOI: 10.1007/s10047-004-0284-6] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2004] [Indexed: 10/25/2022]
Abstract
The current status and future directions of mechanical circulatory support devices (MCSDs) in Japan are reviewed. Currently used clinical MCSDs, both domestic and imported systems and continuous flow devices that are coming into the clinical arena are emphasized. Clinical MCSDs include the extracorporeal pulsatile Toyobo and Zeon systems and the implantable Novacor and HeartMate I VE. A thorough review is presented of single-ventricle continuous flow MCSDs such as the Terumo DuraHeart and the SunMedical EVAHEART and the biventricular Miwatec/Baylor systems that are on the horizon. The future directions in management of end-stage cardiac patients with MCSDs are discussed, focusing on (1) device selection - pulsatile versus continuous flow devices; (2) single-ventricle support, biventricular support, or replacement; (3) bridge to transplantation, destination therapy, or bridge to recovery; and (4) government regulatory processes and the medical industry. We hope to promote the quality of life (QOL) of end-stage cardiac patients as well as the medical industry in Japan.
Collapse
Affiliation(s)
- Setsuo Takatani
- Department of Artificial Organs, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Surugadai, Kanda, Chiyoda-ku, Tokyo, 101-0062, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Nosé Y, Furukawa K. Current status of the gyro centrifugal blood pump--development of the permanently implantable centrifugal blood pump as a biventricular assist device (NEDO project). Artif Organs 2005; 28:953-8. [PMID: 15385004 DOI: 10.1111/j.1525-1594.2004.00073.x] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The New Energy and Industrial Technology Development Organization (NEDO) project was started in 1995. The goal is the development of a multipurpose, totally implantable biventricular assist device (BVAD) that can be used for any patient who suffers from severe heart failure. Our C1E3 (two-week pump) centrifugal pump, called the Gyro pump, has three design characteristics: a magnetic coupling and double pivot bearing system, an eccentric inlet port, and secondary vanes on the bottom of the impeller. The pump was miniaturized. The C1E3 evolved into the NEDO PI-601, a totally implantable centrifugal pump for BVAD. The current NEDO PI-710 pump (five-year pump) system includes a centrifugal pump with pivot bearings, a hydraulically-levitated impeller, an rpm-controlled miniaturized actuator (all-in-one actuator plus controller), an emergency clamp on the left outflow, and a Frank-Starling-type flow control. The final mass production model is now finalized, and the final animal study and two-year endurance studies are ongoing.
Collapse
Affiliation(s)
- Yukihiko Nosé
- Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA.
| | | |
Collapse
|
15
|
Asai T, Watanabe K, Ito S, Tsujimura S, Motomura T, Shinohara T, Glueck JA, Nosé Y. Real-time studies of the pivot bearings in the NEDO Gyro PI-710 centrifugal blood pump. Artif Organs 2005; 28:899-903. [PMID: 15384995 DOI: 10.1111/j.1525-1594.2004.00074.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The NEDO Gyro PI-710 centrifugal pump (Gyro PI-710 pump) incorporates a double pivot bearing system of which the male pivot and female bearings are fabricated from Al2O3 ceramic and ultrahigh molecular weight polyethylene. The top female bearing is a critical component because the impeller is levitated by hydraulic force and is maintained in the top contact position. A long-term in vitro examination of the pivot bearings was conducted using a biventricular assist model. In 7 animal experiments, the depth change of the top female bearing was examined. Animal experiments up to 90 days revealed that there was no noticeable depth increase in the top female bearing. According to the in vitro study, the life of the pivot bearings of the left and right pump was estimated to be approximately 3 and 7 years, respectively. Further improvement of this pivot bearing system is currently underway.
Collapse
|
16
|
Abstract
Implantable ventricular assist devices give hope of a permanent clinical solution to heart failure. These devices, both pulsatile- and continuous-flow, are presently used as medium-term bridge to heart transplant or recovery. While long-term use of continuous-flow axial and centrifugal pumps is being explored, the excessive level of blood damage in these devices has emerged as a design challenge. Blood damage depends both on shear stress and exposure time, and device designers have relied traditionally on global space- and time-averaged estimates from experimental studies to make design decisions. Measuring distributions of shear stress levels and the blood cell's exposure to these conditions in complex rotary pump flow is difficult. On the other hand, computational fluid dynamics (CFD) is now being used as a tool for designing viable devices, offering more detailed information about the flow field. A tensor-based blood damage model for CFD analysis is proposed here. The model estimates the time- and space-dependent strain experienced by individual blood cells and correlates it to blood damage data from steady shear flow experiments. The blood cells are modeled as deforming droplets and their deformation is tracked along the pathlines of a computed flow. The model predicts that blood cells in a rapidly fluctuating shear flow can sustain high shear stress levels for very short exposure time without deforming considerably. In the context of mechanical modeling of the implantable Gyro blood pump being developed at Baylor College of Medicine, this suggests that blood cells traversing regions of highly fluctuating shear stress rapidly may not hemolyze significantly.
Collapse
Affiliation(s)
- Dhruv Arora
- Department of Mechanical Engineering and Materials Science, Rice University, Houston, TX, USA
| | | | | |
Collapse
|
17
|
Watanabe K, Asai T, Ichikawa S, Motomura T, Hata A, Ito S, Shinohara T, Tsujimura S, Oestmann DJ, Nosé Y. Development of a flexible inflow cannula with titanium inflow tip for the NEDO biventricular assist device. ASAIO J 2004; 50:381-6. [PMID: 15307553 DOI: 10.1097/01.mat.0000132555.85820.8e] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
A newly designed flexible inflow cannula has been developed for a biventricular assist device (BVAD). The inflow tip was designed for long-term ventricle drainage. Considering the anatomic differences between the right and left ventricles, a flexible inflow cannula, as a mass production model with a titanium tip, was developed and investigated in chronic BVAD animal experiments using the NEDO permanently implantable centrifugal blood pump. These flexible inflow cannulae consist of flexible plastic tubing with wire supported, titanium left and right tips. The right titanium inflow tip was designed with inner and outer stoppers to be inserted into the right ventricle wall and a beak shape to avoid sucking. The left tip was designed to be inserted into the left ventricle cavity. Five chronic BVAD bovine studies were performed to investigate the new beak shaped titanium tip. In these studies, the new beak shaped titanium tip and cannula prevented stenosis by a proliferation of pseudoneointimal, and supplied adequate blood flow to the pump without sucking. This newly designed inflow cannula with the beak shaped titanium tip was successfully implanted for 90 days.
Collapse
|
18
|
Yamane T, Kodama T, Yamamoto Y, Shinohara T, Nosé Y. Flow visualization in a centrifugal blood pump with an eccentric inlet port. Artif Organs 2004; 28:564-70. [PMID: 15153149 DOI: 10.1111/j.1525-1594.2004.07290.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Flow visualization analysis was applied to the Baylor/Miwatec centrifugal artificial heart to evaluate its fluid dynamic characteristics regarding antithrombogenicity. An eccentric vortex was found both in the upper and the lower gaps of the impeller, which is supposed to be caused by the eccentric inlet port. Therefore, one-way flow toward the outlet is formed and washes the pivot. The combination of an eccentric vortex and a pivot bearing that is washed is unique to the Baylor/Miwatec pump. For the male pivots exposed to periodic wash, the minimum shear rate around the bottom pivot was estimated to be 650/s, which is higher than the threshold for thrombus formation shown by other studies. The wall shear rate at the impeller bottom surface was found to be larger in the top contact mode than in the bottom contact mode.
Collapse
Affiliation(s)
- Takashi Yamane
- National Institute of Advanced Industrial Science and Technology, Namiki 1-2, Tsukuba, Ibaraki 305-8564, Japan.
| | | | | | | | | |
Collapse
|
19
|
Watanabe K, Ichikawa S, Asai T, Motomura T, Hata A, Ito S, Shinohara T, Tsujimura S, Glueck JA, Oestmann DJ, Nosé Y. Centrifugal Blood Pump with a Hydraulically-levitated Impeller for a Permanently Implantable Biventricular Assist Device. Artif Organs 2004; 28:556-63. [PMID: 15153148 DOI: 10.1111/j.1525-1594.2004.07311.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
A permanently implantable biventricular assist device (BVAD) system has been developed with a centrifugal pump which is activated by a hydraulically-levitated impeller. The pump impeller floats hydraulically into the top contact position; this position prevents thrombus formation by creating a washout effect at the bottom bearing area, a common stagnant region. The pump was subjected to in vitro studies using a pulsatile mock circulation loop to confirm the impeller's top contact position and the swinging motion produced by the pulsation. Eleven in vivo BVAD studies confirmed that this swinging motion eliminated blood clot formation. Twenty-one pumps im-planted for up to three months did not reveal any thrombosis in the pumps or downstream organs. One exception was a right pump which was exposed to severe low flow due to the kinking of the outflow graft by the accidental pulling of the flow meter cable. Three ninety-day BVAD studies were achieved without thrombus formation.
Collapse
Affiliation(s)
- Kuniyoshi Watanabe
- DeBakey Department of Surgery, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, U.S.A
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Ichikawa S, Linneweber J, Motomura T, Ishitoya H, Watanabe K, Ashizawa S, Murai N, Nishimura I, Sumikura H, Glueck JA, Shinohara T, Oestmann DJ, Nosé Y. In vivo evaluation of the NEDO biventricular assist device with an RPM dynamic impeller suspension system. ASAIO J 2004; 49:578-82. [PMID: 14524568 DOI: 10.1097/01.mat.0000084104.91081.7b] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
Since 1995, the Baylor College of Medicine group has been developing the NEDO Gyro permanent implantable (PI) pump. The Gyro PI pump has achieved outstanding results up to 284 days with no thrombus formation during the left ventricular assist device (LVAD) animal experiments. However, in biventricular assist device (BVAD) animal experiments, thrombus formation did occur. An in vitro experiment showed the reason for thrombus formation was caused by the missed magnetic balance between the impeller and the actuator. On the basis of this result, the revolutions per minute (RPM) impeller suspension system was developed. Six long-term animal studies were performed in bovine models. Survival periods were 90, 80, 60, 51, 48, and 37 days, respectively. No thrombus was observed in the pumps with the exception of one right pump. In that experiment, the thrombus formation may have occurred when the pump had a low flow because of outflow kinking. In this article, the antithrombogenic effect of this RPM impeller suspension system will be discussed.
Collapse
|
21
|
Ichikawa S, Nonaka K, Motomura T, Ishitoya H, Watanabe K, Ashizawa S, Shinohara T, Sumikura H, Ichihashi F, Oestmann D, Nosé Y. Antithrombogenicity of the Gyro permanently implantable pump with the RPM dynamic suspension system for the impeller. Artif Organs 2004; 27:865-9. [PMID: 14616527 DOI: 10.1046/j.1525-1594.2003.00028.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
In 1995, a group at Baylor College of Medicine started to develop the NEDO biventricular assist device (BVAD) using two Gyro permanently implantable (PI) centrifugal pumps. This pump consists of a sealless pump housing and an impeller supported with a double pivot bearing. In May 2001, an RPM dynamic suspension system (RPM-DS) for the impeller was developed to improve durability and antithrombogenicity without a complex magnetic suspension system. From March 2000 to March 2002, eight BVAD bovine experimental studies were performed for more than 1 month. Two pumps were implanted in two cases without the RPM-DS (group A) and in six cases with the RPM-DS (group B). In group A, the survival period was 45 and 50 days. The primary reason for termination was an increase in the requiring power, which was related to deposition of white thrombus on the bottom bearing. In group B, the survival period was 37, 48, 51, 60, 80, and 90 days. The reasons for termination were not related to thrombus formation. No thrombus was observed in the pumps except for one right pump. In that experiment, the thrombus formation may have occurred when that pump had a low flow rate at a level of 1 L/min for 6 hr. These studies demonstrate the apparent antithrombogenic effect of RPM-DS. The NEDO BVAD is ready to move into a 3-month preclinical system evaluation.
Collapse
Affiliation(s)
- Seiji Ichikawa
- Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Abstract
PURPOSE OF REVIEW Recent advances in technology as well as new indications for implantation have appeared in the field of ventricular assist devices. Progress has also been made in the understanding of the underlying mechanisms of myocardial recovery after ventricular assist device support. RECENT FINDINGS Technological progress includes the development of fully implantable pulsatile and continuous flow pumps, either axial flow or centrifugal, for left ventricular and total heart assistance. Among the new indications for ventricular assist device support, the most important is the use of the device as permanent treatment for end-stage cardiac failure patients. Increased knowledge has been acquired regarding the effects of mechanical assistance and of unloading of the heart on haemodynamics, as well as on the cellular, molecular and electrophysiological characteristics of the failing heart. All these findings suggest that depressed myocardial function can sometimes recover with ventricular assist device therapy. Ventricular assist device support, however, still carries a high rate of complications: the device itself can fail, bleeding and thromboembolism are common, immunity is disturbed and the incidence of infection remains high. SUMMARY In patients with end-stage heart failure, ventricular assist devices can be used as a bridge to transplantation or to recovery, but they are now also considered as a long-term myocardial replacement therapy. Which device is the most appropriate for each indication, however, remains to be defined. Even if the underlying mechanisms of myocardial recovery are progressively clarified, the use of ventricular assist devices as a bridge to recovery still has limited clinical success. Clinical trials with the fully implantable devices are in their early stages, but these pumps appear promising in terms of efficacy, reliability and complication rate, as well as being easy to implant. Because more patients will benefit from ventricular assist device placement in the future, anaesthesiologists must be prepared to manage patients undergoing ventricular assist device placement or presenting for noncardiac surgery while under ventricular assist device support.
Collapse
Affiliation(s)
- Edith Collard
- Department of Anaesthesiology, Université Catholique de Louvain, Belgium.
| | | | | |
Collapse
|
23
|
Abstract
During the past 10 years, different types of blood pumps were developed to address various clinical needs. The Nikkiso centrifugal blood pump was developed for cardiopulmonary bypass application. This blood pump has been widely used in Japan in more than 20% of the cardiopulmonary bypass procedures. The Kyocera C1E3 Gryo pump was developed for short-term circulatory assistance and extracorporeal membrane oxygenation application for up to 2 weeks. This blood pump has been clinically used for up to 28 days without any blood clot formation. Through Phase I of the Japanese government New Energy and Industrial Technology Development Organization (NEDO) program, a chronically implanted centrifugal pump for left ventricular assistance was developed. This pump has already demonstrated its effectiveness, safety, and durability as a 2 year blood pump through in vitro and in vivo experiments. Currently, it is in the process of being converted from an experimental to a clinical device. Through Phase II of the NEDO program, a permanently implantable biventricular assist centrifugal blood pump system is under development. It has demonstrated that the previously mentioned left ventricular assist device blood pump is easily converted into a right ventricular assist pump by simply adding a spacer between the pump and the actuator. This communication discusses the historical development strategies for centrifugal blood pumps and their current status for different clinical needs.
Collapse
Affiliation(s)
- Seiji Ichikawa
- Michael E DeBakey Department of Surgery, Artificial Organ Research Laboratory, Baylor College of Medicine, Houston, Texas 77030, USA
| | | |
Collapse
|
24
|
Ichikawa S, Nishimura I, Mikami M, Nonaka K, Linneweber J, Kawahito S, Motomura T, Ishitoya H, Glueck J, Shinohara T, Nosé Y. The balance of the impeller-driver magnet affects the antithrombogenicity in the Gyro permanently implantable pump. Artif Organs 2002; 26:927-30. [PMID: 12406145 DOI: 10.1046/j.1525-1594.2002.07120.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The Gyro permanently implantable (PI) pump is activated magnetically when a double pivot bearing supported impeller is rotated at predetermined revolutions per minute (rpm). The male bearing shaft of the impeller is supported by the top and bottom female pivot bearing in a loosely mated fashion. The Gyro PI pump's impeller transfers to a floating condition when the rpm is increased. The design objective of the Gyro PI pump is to drive the impeller while maintaining a top contact position to prevent thrombus formation. As a left ventricular assist device (LVAD), the Gyro PI pumps achieved long-term survivals in calves without thrombus formation. However, thrombus formation occurred during a biventricular assist device (BVAD) implantation. Our hypothesis was that the impeller remaining in the bottom contact position during the BVAD experiment caused this thrombus formation. Therefore, a replica of the Gyro PI pump housing was fabricated from a transparent plastic to observe the floating conditions of the impeller. When simulating an LVAD animal experiment, the impeller was at a non-bottom contact position. However, when simulating the BVAD animal experiment, the impeller remained at the bottom contact position. This study shows that the magnet balance affects the antithrombogenicity in a Gyro PI pump.
Collapse
Affiliation(s)
- Seiji Ichikawa
- Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|